Corrigendum: Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment.

Frontiers in Oncology(2024)

引用 0|浏览4
暂无评分
摘要
[This corrects the article DOI: 10.3389/fonc.2023.1191611.].
更多
查看译文
关键词
cancer of unknow primary,PET/CT (18)F-FDG,sunitinb,EFGR,VEGFR
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要